Trial no.:
|
PACTR201911569413211 |
Date of Approval:
|
12/11/2019 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Dry Needling versus Integrated Neuromuscular Inhibition Techniques on Upper Trapezius in Myofascial Pain Syndrome
|
Official scientific title |
Dry Needling versus Integrated Neuromuscular Inhibition Technique on Upper Trapezius in Myofascial Pain Syndrome on Pain Intensity and Neck Disability Function
|
Brief summary describing the background
and objectives of the trial
|
The incidence of myofacial pain syndrome with associated trigger points appears to vary between people of any age, but the greatest number were between the ages of 21-50 years old . MTrPs occur in both sexes although it appears to be more common in females than males .. Myofascial trigger points are the primary source of musculoskeletal pain in 21-85% of patients Dry needling (DN) is one of physical therapy treatment for MTrPs which is safe and settled by several studies . The effect of DN on MTrPs of the upper trapezius muscle have demonstrated reduced pain intensity and pain pressure threshold (PPT). It can disrupt the neuromuscular activity dysfunctional in the muscles, decrease muscle tone and normalize the neurochemical pathways of muscles, increased local blood flow, restored range of motion at the neck, and improved quality of life
Integrated neuromuscular inhibition technique(INIT) is a manual therapy technique consisted of muscle energy techniques (MET), ischemic compression (IC) and strain-counterstrain (SCS). It was settled and found to be effective in treatment of MTrPs and more beneficial in relieving pain , reducing stiffness, and improving functional ability .So The study will be conducted to answer the following research question: Which will be more effective dry needling or integrated neuromuscular inhibition technique in treatment of active MTrPs of upper trapezius muscle.?
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
MTrPs DN INIT IC MET SCS |
Disease(s) or condition(s) being studied |
Musculoskeletal Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
01/10/2019 |
Actual trial start date |
05/10/2019 |
Anticipated date of last follow up |
01/12/2019 |
Actual Last follow-up date |
19/12/2019 |
Anticipated target sample size (number of participants) |
80 |
Actual target sample size (number of participants) |
60 |
Recruitment status |
Not yet recruiting |
Publication URL |
|
|